Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
about
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerRLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancerRole of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76RLIP76: a versatile transporter and an emerging target for cancer therapy.RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells.Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progressionEmerging treatments in lung cancer - targeting the RLIP76 molecular transporter.Identification of differentially expressed proteins in ovarian cancer using high-density protein microarraysGlutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis.Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells.Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastomaDelivery of intracellular-acting biologics in pro-apoptotic therapies.Therapeutic resistance in lung cancer.Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76RLIP76: A novel glutathione-conjugate and multi-drug transporter.Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugatesRLIP76 in defense of radiation poisoning.Regression of prostate cancer xenografts by RLIP76 depletion.hSET1: a novel approach for colon cancer therapyRLIP76 and Cancer.Physiological and pharmacological significance of glutathione-conjugate transport.RLIP76 Targeted Therapy for Kidney CancerRLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer.Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.RalA is overactivated in medulloblastoma.RalA suppresses early stages of Ras-induced squamous cell carcinoma progression.RLIP76: a target for kidney cancer therapy.Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosisMitogenic and drug-resistance mediating effects of PKCalpha require RLIP76.Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer.P300 regulates the human RLIP76 promoter activity and gene expressionEpsins' novel role in cancer cell invasion.A photoelectrochemical platform for the capture and release of rare single cells.
P2860
Q28396304-AA591102-9902-4A92-9D12-97D650ED1586Q28482104-FE08A239-C126-4F91-8E13-675183D28195Q30051796-2D956522-C247-44B9-AAB2-43020E74B4C9Q33867008-62534CE1-02FB-4A19-B1AF-048B75501BBCQ34072657-A9265C52-9B34-4FA9-814D-76081BDFBD47Q34294188-5DBCE1B0-B06D-4C32-BDF8-C0A1B9518D0DQ34556062-777AD9AE-AC0C-43C8-B4F8-15526E8BDF39Q34705309-E0337082-FEE2-4495-8348-2BD088150642Q34729947-D20A54DA-899D-4A3B-A8DA-A21285DE1135Q35787969-F9DA12A3-573E-48AA-BDB6-2D8DE7C879D1Q35803397-9404E3CD-DE68-4005-B01D-25F74D743410Q36588920-14DECCB9-28BB-4D33-8F35-462D84A10401Q36609767-63924698-40C6-4FA1-AE54-59C2CBEB5A92Q36744205-2F2D608C-E490-42A8-B1EF-65C1B9B9CBFCQ36982690-F4F5AAD6-90D1-462D-B074-1A81EF2B827BQ37146979-7FAA2DE4-E71D-46C7-85B5-51F00C2A8392Q37146994-0414721D-26F4-413E-925C-278EA0F9CBE4Q37146998-7773C03E-806A-48D1-AB3A-4E703A7E4515Q37194622-27522928-C7B6-4E05-9CBE-13105F5C2145Q37215471-7BA5FE89-F80F-42A6-B045-C0AD2FE9D5D9Q37217140-923E0598-F87D-4520-B02C-54EB92FEDE79Q37698426-42CD0837-6493-4113-8F94-22205865D4C6Q37741408-7DEEBF82-E3C5-4B0C-80B5-0EE1AB2C5307Q38749340-6C03F3CD-2866-45C9-8A98-80868D3BDDEDQ39215770-946F52C4-8468-40CE-BA75-17F329D98E5EQ39449209-A1BCA377-0C45-4D96-8721-2D0238F394DEQ39791607-7B312E9B-0BA8-4845-9DAD-52FDBA57506EQ39856444-ECF4D841-5E69-47E9-9FB6-2A3EDF6A8848Q39859514-75AE02B2-48E8-47CE-8343-49192E9DFEE6Q40247154-EAEC46EA-F98C-4514-8773-9C3B322ADE82Q40297526-FA11A45D-AF5F-40CF-A9FF-576FEF7014E6Q40387322-86C57D57-8169-4837-AF68-4F0D679AD873Q42051924-CF7EE1E6-D3C7-4EC8-8339-EEA79B4C3460Q42119540-F03CC135-DB6F-48F0-9096-008DE453D77AQ55206279-46E23E0B-AA69-4876-85AF-BB9C7C86EFD1
P2860
Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
@en
type
label
Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
@en
prefLabel
Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
@en
P2093
P1476
Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
@en
P2093
Jyotsana Singhal
Sanjay Awasthi
Sharad S Singhal
Sushma Yadav
Yogesh C Awasthi
P304
P356
10.1016/J.BCP.2005.05.005
P407
P577
2005-08-01T00:00:00Z